Quarterly report pursuant to Section 13 or 15(d)

Supplemental balance sheet information (Tables)

v3.24.1.1.u2
Supplemental balance sheet information (Tables)
3 Months Ended
Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
Schedule of Cash, Cash Equivalents, and Restricted Cash

Cash, cash equivalents, and restricted cash are recorded in our unaudited condensed consolidated balance sheet as follows:

 

 

March 31,

 

 

 

2024

 

 

2023

 

Cash and cash equivalents

 

$

28.3

 

 

$

69.9

 

Restricted cash included in prepaid expenses and other current assets

 

 

 

 

 

2.8

 

Total cash, cash equivalents, and restricted cash

 

$

28.3

 

 

$

72.7

 

Summary of Inventories

Inventories are comprised of the following:

 

 

March 31,
2024

 

 

December 31,
2023

 

Raw materials and supplies

 

$

74.6

 

 

$

84.2

 

Work in process

 

 

21.1

 

 

 

20.5

 

Finished products and parts

 

 

124.1

 

 

 

131.9

 

Total

 

$

219.8

 

 

$

236.6

 

Summary of Accrued Expenses

Accrued expenses are comprised of the following:

 

 

March 31,
2024

 

 

December 31,
2023

 

Employee compensation and benefits

 

$

37.2

 

 

$

22.6

 

Sales, use, and property taxes

 

 

16.8

 

 

 

24.0

 

Insurance

 

 

10.9

 

 

 

10.9

 

Interest

 

 

21.2

 

 

 

5.4

 

Income taxes

 

 

1.6

 

 

 

1.5

 

Other

 

 

1.3

 

 

 

1.2

 

Total accrued expenses

 

$

89.0

 

 

$

65.6

 

Summary of Other Current Liabilities

Other current liabilities are comprised of the following:

 

 

March 31,
2024

 

 

December 31,
2023

 

Acquired contract liabilities

 

$

35.6

 

 

$

43.5

 

Accrued legal contingencies

 

 

10.8

 

 

 

20.7

 

Deferred revenue

 

 

3.3

 

 

 

7.3

 

Tax receivable agreement obligation

 

 

6.4

 

 

 

2.8

 

Other

 

 

8.3

 

 

 

9.8

 

Total other current liabilities

 

$

64.4

 

 

$

84.1